Paul Peter Tak - 21 Nov 2024 Form 4 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Executive Officer, Director
Signature: /s/ Charles Schoch as Attorney-in-Fact for Paul Peter Tak
Issuer symbol: CADL
Transactions as of: 21 Nov 2024
Net transactions value: +$19,995
Form type: 4
Filing time: 21 Nov 2024, 15:07:23 UTC
Previous filing: 19 Jul 2024
Next filing: 03 Dec 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CADL	Common Stock	Options Exercise	$19,995	+12,900	+3.9%	$1.55	343,635	21 Nov 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CADL	Stock Option (Right to Buy)	Options Exercise	$0	-12,900	-0.73%	$0.000000	1,763,968	21 Nov 2024	Common Stock	12,900	$1.55	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of this option vested and became exercisable on October 10, 2020, with another 25% vesting on October 10, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.